tibolone has been researched along with fibrinogen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, A; Jackson, G; Lloyd, G; Lumb, PJ; McGing, E; Patel, N; Wierzbicki, AS | 1 |
Byrne, DJ; Ginsburg, J; Jagroop, IA; Kwong, P; Mikhailidis, DP; Prelevic, GM | 1 |
Al-Amin, H; Beaini, M; Daher, R; Usta, I | 1 |
Oztekin, K; Sahin, F; Saraç, F; Saydam, G; Saygili, F; Tüzün, M; Yilmaz, C | 1 |
Banach, M; Bała, M; Lip, GYH; Mikhailidis, DP; Rysz, J; Sahebkar, A; Serban, MC; Undas, A; Ursoniu, S | 1 |
1 review(s) available for tibolone and fibrinogen
Article | Year |
---|---|
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta-analysis of controlled trials.
Topics: Antithrombin III; Controlled Clinical Trials as Topic; Estrogen Receptor Modulators; Fibrinogen; Humans; Norpregnenes | 2017 |
2 trial(s) available for tibolone and fibrinogen
Article | Year |
---|---|
A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women.
Topics: Antihypertensive Agents; Blood Pressure; Demography; Double-Blind Method; Female; Fibrinogen; Hormone Replacement Therapy; Humans; Hypertension; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Norpregnenes; Quality of Life | 2000 |
Effect of tibolone therapy on lipids and coagulation indices.
Topics: Antithrombin III; Blood Coagulation; Blood Coagulation Factors; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estrogen Receptor Modulators; Female; Fibrinogen; Homocysteine; Humans; Lipid Metabolism; Lipids; Lipoprotein(a); Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Protein C; Treatment Outcome; Triglycerides | 2006 |
2 other study(ies) available for tibolone and fibrinogen
Article | Year |
---|---|
A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women.
Topics: Administration, Cutaneous; Aged; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelin-1; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Fibrinogen; Glycated Hemoglobin; Humans; Insulin; Lipids; Middle Aged; Norpregnenes; Postmenopause; Risk Factors | 2002 |
Effects of hormone replacement therapy on insulin resistance and platelet function tests.
Topics: Adult; Analysis of Variance; Body Weights and Measures; C-Reactive Protein; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Homeostasis; Hormone Replacement Therapy; Humans; Hysterectomy; Insulin Resistance; Middle Aged; Norpregnenes; Platelet Function Tests; Postmenopause; Turkey | 2009 |